Cargando…
Immunosurveillance shapes the emergence of neo-epitope landscapes of sarcomas, revealing prime targets for immunotherapy
T cells recognize tumor-derived mutated peptides presented on MHC by tumors. The recognition of these neo-epitopes leads to rejection of tumors, an event that is critical for successful cancer immunosurveillance. Determination of tumor-rejecting neo-epitopes in human tumors has proved difficult, tho...
Autores principales: | Osei-Hwedieh, David O., Sedlacek, Abigail L., Hernandez, Luis Mena, Yamoah, Archibald Agyekum, Iyer, Swati G., Weiss, Kurt R., Binder, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371341/ https://www.ncbi.nlm.nih.gov/pubmed/37427594 http://dx.doi.org/10.1172/jci.insight.170324 |
Ejemplares similares
-
A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas
por: Crowe, Nadine Y., et al.
Publicado: (2002) -
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas
por: Schreiber, T H, et al.
Publicado: (2009) -
Identification and ranking of recurrent neo-epitopes in cancer
por: Blanc, Eric, et al.
Publicado: (2019) -
β-catenin-mediated inhibition of cross-priming: A new mechanism for tumors to evade immunosurveillance
por: Fu, Chunmei, et al.
Publicado: (2013) -
The heat shock protein-CD91 pathway mediates tumor immunosurveillance
por: Zhou, Yu Jerry, et al.
Publicado: (2014)